Chief Financial Officer
Muhammed Omar Faruk Ripon FCA
Mr. Muhammed Omar Faruk Ripon is an accounting professional having a wide range of work experience more than 20 (twenty) years in the field of Finance, Accounts, Tax, VAT, Internal Audit & Compliance. Currently, Mr. Omar serves as CFO, in the position of Sr. Executive Director, of Walton Hi-Tech Industries PLC. He joined the company in 2019. He has proven track record of leading financial strategies to facilitate the company’s ambitious growth plans. He is also responsible to ensure compliance and statutory reporting. Mr. Omar possesses the ability to provide a high standard of financial control and ensuring legal & regulatory compliance relating to taxation. He is also accountable for expenditure tracking, operating budgets and preparing long range financial plans for the company. As CFO, he also works in assisting business units in their budgeting and planning process. Ensuring preparation and dissemination of timely and accurate financial information to allow for efficient use and control over financial resources of the company also fall under some of his major tasks. He is Fellow member of the Institute of Chartered Accountants of Bangladesh. He also holds degree in Master of Commerce and L.L.B from National University and PL-I qualifies from the Institute of Chartered Secretaries of Bangladesh. He is member of the Information & Communication Technology Committee (ICTC) of the Council of ICAB and Article writer of Quarterly Journal ‘The Bangladesh Accountant’ of ICAB. During his long course of career, he has undergone many trainings on Tax, VAT, Customs Bond Management, Financial Management & Reporting, Project Management, Transfer Pricing, Export Marketing, Code of Ethics, Internal Control, Corporate Governance, Leadership & Change Management, Effective Communication and many more from different institutes such as the World Bank, CPA Ireland, ICSB, ICAB, ICGAB, IIAB, NBR, BIPET, BVPF. Before joining Walton Hi-Tech Industries Limited, Mr. Omar served for The ACME Laboratories Ltd., Square Pharmaceuticals Ltd. and National Polymer Industries Ltd. for a period of 5 years, 6 years and 7 years respectively in various capacities.